Form 4: Autonomix Medical CEO Bradley Hauser Acquires 900,000 Options

Autonomix Medical's CEO, Bradley Hauser, reports the acquisition of 900,000 options in the company, vesting over four years.

Summary

• Bradley Hauser, CEO and President of Autonomix Medical, Inc. acquired 900,000 options on June 17, 2024.
• The options have an exercise price of $1.35.
• The options vest in four equal annual installments starting on the first anniversary of the transaction date, contingent upon continued service to the company.
• The options expire on June 17, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock option grants to the CEO. The vesting schedule suggests a long-term commitment.

Positives

• The CEO's acquisition of options may signal confidence in the company's future performance.

Industry Context

This is a standard SEC Form 4 filing, reporting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the trading activities of company executives.

Stakeholder Impact

• The acquisition of options by the CEO could be viewed positively by shareholders, as it aligns the CEO's interests with the company's long-term success.

Key Dates

Keywords

options, Autonomix Medical, Form 4, insider trading, Bradley Hauser, AMIX, CEO